Robot-assisted surgery is a game changer, not only for orthopedic device companies but the contract manufacturers serving them. For major supplier Tecomet, it means forging relationships earlier, sometimes tighter instrument tolerances — and much more. It makes sense that Tecomet officials would see the rise of robot-assisted surgery in the ortho space as a big […]
Report: Genstar Capital shops Tecomet for $1B
Private equity player Genstar Capital is reportedly shopping Tecomet to potential buyers for more than $1 billion. Genstar tapped investment bank William Blair & Co. to auction Tecomet, according to Reuters, which cited “people familiar with the matter.” Genstar, Tecomet and William Blair declined to comment. Wilmington, Mass.-based Tecomet, founded in 1963, is a contract manufacturer […]
Tecomet to shutter Symmetry Medical plants, laying off 319 workers
2014: The year of the medtech IPO | Medtech Wall Street news for the week of December 15, 2014
Hologic CEO gives glowing review to major stakeholder and activist investor Carl Icahn | Medtech Wall Street news for the week of August 4, 2014
Symmetry Medical sells its OEM biz to Tecomet for $450M
Symmetry Medical’s (NYSE:SMA) going through some big changes, selling off its orthopedics components division and spinning out its surgical business.
PE player takes out Tecomet
Genstar Capital said it bought out Tecomet, a medical device OEM, for an undisclosed amount.
Genstar Capital is a private equity firm, focused on investments in technology, healthcare, and finance industries.
Wilmington, Mass.-based Tecomet makes orthopedic implants, precision surgical instruments and photochemical etched products for medical device customers. The company has been around since the 1960s and was recently a Charlesbank Capital Partners company. Genstar plans on leaving management in place, according to a press release.
